Specify a stock or a cryptocurrency in the search bar to get a summary
BiondVax Pharmaceuticals Ltd ADR
BVXVBiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel. Address: Jerusalem BioPark Building, Jerusalem, Israel
Analytics
WallStreet Target Price
39 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BVXV
Dividend Analytics BVXV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BVXV
Stock Valuation BVXV
Financials BVXV
Results | 2019 | Dynamics |